4//SEC Filing
Kaiser Peter 4
Accession 0001104659-25-097165
CIK 0001393434other
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 5:13 PM ET
Size
5.8 KB
Accession
0001104659-25-097165
Insider Transaction Report
Form 4
Kaiser Peter
Chief Development Officer
Transactions
- Sale
Common Stock
2025-10-02$11.03/sh−9,653$106,473→ 194,440 total
Footnotes (2)
- [F1]Represents shares of common stock of Ocular Therapeutix, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on October 1, 2025. The sales do not represent a discretionary trade by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.99 to $11.0697, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Documents
Issuer
OCULAR THERAPEUTIX, INC
CIK 0001393434
Entity typeother
Related Parties
1- filerCIK 0002011869
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 5:13 PM ET
- Size
- 5.8 KB